CN109157539A - 具有改善的干燥保护和保留的眼用组合物 - Google Patents
具有改善的干燥保护和保留的眼用组合物 Download PDFInfo
- Publication number
- CN109157539A CN109157539A CN201811311427.8A CN201811311427A CN109157539A CN 109157539 A CN109157539 A CN 109157539A CN 201811311427 A CN201811311427 A CN 201811311427A CN 109157539 A CN109157539 A CN 109157539A
- Authority
- CN
- China
- Prior art keywords
- composition
- composition according
- concentration
- hyaluronic acid
- guar gum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
成分 | %W/V |
羟丙基瓜尔胶 | 0.025至0.8 |
透明质酸钠 | 0.13至0.17 |
硼酸 | 0.35 |
山梨糖醇 | 1.4 |
PEG 400 | 0.4 |
EDTA钠 | 0.025 |
丙二醇 | 0.3 |
氯化钾 | 0.12 |
氯化钠 | 0.1 |
聚季铵-1 | 0.001+10%过量 |
2-氨基-2-甲基丙醇 | 0.27 |
氢氧化钠/盐酸 | q.s.pH 7.9 |
纯化水 | q.s.100% |
组合物 | 荧光标记 | 保留的荧光% |
透明质酸(HA) | 荧光素钠 | 5.46±1.46 |
羟丙基瓜尔胶/透明质酸(HPG/HA) | 荧光素钠 | 11.03±2.85<sup>e</sup> |
羟丙基瓜尔胶(HPG) | 得克萨斯红 | 8.58±2.69 |
羟丙基瓜尔胶/透明质酸(HPG/HA) | 得克萨斯红 | 11.60±3.96 |
组合物 | 荧光标记 | 保留的荧光% |
透明质酸(HA) | 荧光素钠 | 3.25±0.91 |
羟丙基瓜尔胶/透明质酸(HPG/HA) | 荧光素钠 | 7.85±1.94<sup>f</sup> |
透明质酸/羧甲基纤维素(HA/CMC) | 荧光素钠 | 3.17±0.78 |
制剂 | 干燥保护(%) | 保留保护(%) |
冰蓝润眼液 | 10±7 | 3±7 |
冰蓝凝胶润眼液 | 25±8 | 7±10 |
HPG/HA | 57±13<sup>g</sup> | 43±12<sup>h</sup> |
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261642901P | 2012-05-04 | 2012-05-04 | |
US61/642,901 | 2012-05-04 | ||
CN201380031008.8A CN104379131A (zh) | 2012-05-04 | 2013-05-03 | 具有改善的干燥保护和保留的眼用组合物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380031008.8A Division CN104379131A (zh) | 2012-05-04 | 2013-05-03 | 具有改善的干燥保护和保留的眼用组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109157539A true CN109157539A (zh) | 2019-01-08 |
Family
ID=48464107
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380031008.8A Pending CN104379131A (zh) | 2012-05-04 | 2013-05-03 | 具有改善的干燥保护和保留的眼用组合物 |
CN201811311427.8A Pending CN109157539A (zh) | 2012-05-04 | 2013-05-03 | 具有改善的干燥保护和保留的眼用组合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380031008.8A Pending CN104379131A (zh) | 2012-05-04 | 2013-05-03 | 具有改善的干燥保护和保留的眼用组合物 |
Country Status (19)
Country | Link |
---|---|
US (6) | US20130296264A1 (zh) |
EP (1) | EP2844226B1 (zh) |
KR (1) | KR102076033B1 (zh) |
CN (2) | CN104379131A (zh) |
AR (1) | AR090930A1 (zh) |
AU (1) | AU2013256144B2 (zh) |
BR (1) | BR112014027582B1 (zh) |
CA (1) | CA2872622C (zh) |
DK (1) | DK2844226T3 (zh) |
ES (1) | ES2761373T3 (zh) |
IN (1) | IN2014MN02248A (zh) |
MX (1) | MX362266B (zh) |
PH (1) | PH12014502571A1 (zh) |
PL (1) | PL2844226T3 (zh) |
PT (1) | PT2844226T (zh) |
RU (1) | RU2659207C2 (zh) |
UA (1) | UA113434C2 (zh) |
WO (1) | WO2013166399A1 (zh) |
ZA (1) | ZA201408490B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9492474B2 (en) | 2013-07-10 | 2016-11-15 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
US10245324B2 (en) * | 2014-10-31 | 2019-04-02 | Johnson & Johnson Consumer Inc. | Ophthalmic composition |
CN105311042B (zh) * | 2015-09-07 | 2019-04-12 | 广州国宇医药科技有限公司 | 一种糖醇组合物在制备治疗干眼症的药物中的应用 |
PT3352766T (pt) | 2015-09-24 | 2022-03-22 | Matrix Biology Inst | Composições de hialuronano de elevada elasticidade e processos para o seu uso |
US10632202B2 (en) | 2016-03-04 | 2020-04-28 | Johnson & Johnson Consumer Inc. | Preservative containing compositions |
TW201938141A (zh) * | 2018-02-21 | 2019-10-01 | 瑞士商諾華公司 | 基於脂質的眼用乳劑 |
TWI757773B (zh) * | 2019-06-28 | 2022-03-11 | 瑞士商愛爾康公司 | 眼用組成物 |
CN114191378A (zh) * | 2021-11-23 | 2022-03-18 | 温州医科大学附属眼视光医院 | 一种地夸磷索缓释凝胶及其制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090270345A1 (en) * | 2008-04-26 | 2009-10-29 | Alcon Research, Ltd. | Polymeric artificial tear system |
US20100087550A1 (en) * | 2008-10-06 | 2010-04-08 | Zora Marlowe | Formulations with a Tertiary Amine Oxide |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09227385A (ja) * | 1996-02-29 | 1997-09-02 | Ofutekusu:Kk | 眼手術用補助剤 |
EP1348427B1 (en) | 1997-07-29 | 2008-04-09 | Alcon Laboratories, Inc. | Ophthalmic compositions containing galactomannan polymers and borate |
AU2004249137B2 (en) * | 2003-06-13 | 2010-03-11 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
JP5431965B2 (ja) * | 2007-02-09 | 2014-03-05 | アルコン,インコーポレイテッド | 3種のポリマーの相乗的組み合わせを含む眼科用組成物 |
US20090036554A1 (en) * | 2007-08-01 | 2009-02-05 | Burke Susan E | Ophthalmic compositions comprising a terpene compound |
US9096819B2 (en) * | 2008-01-31 | 2015-08-04 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer |
EP2566447B1 (en) * | 2010-05-05 | 2020-07-15 | Alcon Inc. | Stabilized ophthalmic galactomannan formulations |
-
2013
- 2013-03-05 UA UAA201412705A patent/UA113434C2/uk unknown
- 2013-05-03 AU AU2013256144A patent/AU2013256144B2/en active Active
- 2013-05-03 CA CA2872622A patent/CA2872622C/en active Active
- 2013-05-03 US US13/886,788 patent/US20130296264A1/en not_active Abandoned
- 2013-05-03 IN IN2248MUN2014 patent/IN2014MN02248A/en unknown
- 2013-05-03 WO PCT/US2013/039487 patent/WO2013166399A1/en active Application Filing
- 2013-05-03 ES ES13723623T patent/ES2761373T3/es active Active
- 2013-05-03 MX MX2014013444A patent/MX362266B/es active IP Right Grant
- 2013-05-03 KR KR1020147032805A patent/KR102076033B1/ko active IP Right Grant
- 2013-05-03 RU RU2014148758A patent/RU2659207C2/ru active
- 2013-05-03 PL PL13723623T patent/PL2844226T3/pl unknown
- 2013-05-03 EP EP13723623.8A patent/EP2844226B1/en active Active
- 2013-05-03 AR ARP130101515A patent/AR090930A1/es unknown
- 2013-05-03 CN CN201380031008.8A patent/CN104379131A/zh active Pending
- 2013-05-03 DK DK13723623.8T patent/DK2844226T3/da active
- 2013-05-03 BR BR112014027582-3A patent/BR112014027582B1/pt active IP Right Grant
- 2013-05-03 PT PT137236238T patent/PT2844226T/pt unknown
- 2013-05-03 CN CN201811311427.8A patent/CN109157539A/zh active Pending
-
2014
- 2014-11-19 ZA ZA2014/08490A patent/ZA201408490B/en unknown
- 2014-11-19 PH PH12014502571A patent/PH12014502571A1/en unknown
-
2017
- 2017-02-01 US US15/421,513 patent/US20170136057A1/en not_active Abandoned
-
2019
- 2019-12-19 US US16/721,443 patent/US10828320B2/en active Active
-
2020
- 2020-10-01 US US17/060,343 patent/US11376275B2/en active Active
-
2022
- 2022-05-19 US US17/664,143 patent/US11672820B2/en active Active
-
2023
- 2023-05-17 US US18/319,196 patent/US20230285443A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090270345A1 (en) * | 2008-04-26 | 2009-10-29 | Alcon Research, Ltd. | Polymeric artificial tear system |
US20100087550A1 (en) * | 2008-10-06 | 2010-04-08 | Zora Marlowe | Formulations with a Tertiary Amine Oxide |
Non-Patent Citations (4)
Title |
---|
凌沛学主编: "《透明质酸》", 30 August 2000, 中国轻工业出版社 * |
周建平主编: "《药剂学进展》", 30 June 2008, 江苏科学技术出版社 * |
易杨华主编: "《海洋药物导论》", 30 September 2004, 上海科学技术出版社 * |
郑俊民主编: "《药用高分子材料学》", 31 January 2009, 中国医药科技出版社 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11376275B2 (en) | Ophthalmic compositions with improved dessication protection and retention | |
US6486138B1 (en) | Ophthalmic compositions containing galactomannan polymers and borate | |
AU2011248129B2 (en) | Stabilized ophthalmic galactomannan formulations | |
WO2006112029A1 (ja) | 眼科用組成物 | |
AU2012284291B2 (en) | Pharmaceutical compositions comprising plant-based polysaccharides and uses thereof | |
JP2006117656A (ja) | ヒアルロン酸又はその塩を含有する粘膜適用組成物 | |
JP2019182825A (ja) | 眼科組成物 | |
CA2947274A1 (en) | Ophthalmic compositions and methods for treating eyes | |
WO2005060933A1 (en) | Ophthalmic compositions containing a polysaccharide/borate gelling system | |
JP2006225323A (ja) | 水性外用組成物 | |
JP2006248960A (ja) | 水性外用組成物 | |
CN111050777B (zh) | 提供改善的眼睛舒适度的组合物 | |
JP2006143590A (ja) | 粘膜適用組成物 | |
KR102485523B1 (ko) | 안과용 조성물 | |
JP2020510088A (ja) | 新規な粘弾性溶液及びそのリウマチ学における使用 | |
AU2017260839A1 (en) | Ophthalmic composition comprising a synergistic combination of glycogen and hyaluronic acid or a salt thereof | |
JP2005187354A (ja) | 水性外用剤組成物 | |
CN112165948A (zh) | 用于治疗眼部症状的多糖 | |
EP0888770A1 (en) | Compositions comprising cationic polysaccharides and cationic drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20191128 Address after: Fribourg Applicant after: ALCON, Inc. Address before: Texas, USA Applicant before: Alcon Research Co.,Ltd. Effective date of registration: 20191128 Address after: Texas, USA Applicant after: Alcon Research Co.,Ltd. Address before: Texas, USA Applicant before: ALCON RESEARCH, Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190108 |